PEPTIDE RESEARCH TOPIC

CJC-1295 Research Peptide

Explore CJC-1295 terminology, DAC and no-DAC distinctions, research context, comparisons, and handling information.

TOPIC OVERVIEW

About CJC-1295

Molecular design

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone designed for prolonged activity.

  • The Drug Affinity Complex, or DAC, enables covalent association with circulating albumin and extends exposure.
  • CJC-1295 without DAC and modified GRF 1-29 are often used as market labels, but they should not be assumed to be the same molecule as DAC-containing CJC-1295.

GHRH signaling

CJC-1295 acts through the GHRH receptor on pituitary somatotroph cells.

  • Early controlled studies in healthy adults measured sustained changes in growth hormone and IGF-1 while preserving pulsatile GH secretion.
  • Research questions include duration, albumin binding, endocrine markers, sequence identity, stability, and comparisons with ghrelin-receptor agonists.
  • The exact sequence and conjugation state determine which evidence is relevant.

Evidence and naming limits

Human evidence is limited to small early studies and does not establish broad clinical use.

  • CJC-1295 is not generally approved as a therapeutic medicine.
  • Online “DAC” and “no-DAC” labels require analytical confirmation because naming practices are inconsistent across suppliers.
Topics covered
  • GHRH analog terminology
  • DAC and no-DAC distinctions
  • sequence verification
  • storage and stability
  • purity and supplier documentation
Common names and related terms: cjc-1295, cjc 1295, cjc1295, cjc-1295 dac, cjc-1295 no dac
CJC-1295 KNOWLEDGE ARTICLESPage 13 of 25
02
KNOWLEDGE ARTICLE

Tesamorelin CJC 1295 Ipamorelin: Stack Guide

Learn how tesamorelin CJC 1295 ipamorelin work together, typical stack dosages, differences, safety, and legal status. Informational guide for US researchers.

↗
03
KNOWLEDGE ARTICLE

What Happens When You Stop Taking CJC-1295?

What happens when you stop taking cjc-1295? Learn how GH and IGF-1 levels shift, which side effects fade, and what to expect in the weeks after.

↗
05
KNOWLEDGE ARTICLE

How to Reconstitute CJC-1295 Ipamorelin Safely

Learn how to reconstitute CJC-1295 ipamorelin with bacteriostatic water, correct dosing math, storage tips, and safety notes for research use only.

↗
08
KNOWLEDGE ARTICLE

CJC-1295 No DAC and GHRP-6 Dosage Guide

CJC-1295 no DAC and GHRP-6 dosage is often discussed together. Learn typical research amounts, timing, safety, and how they compare to GHRP-2.

↗
11
KNOWLEDGE ARTICLE

CJC-1295 Side Effects: What to Know Before Use

CJC-1295 side effects include flushing, injection site reactions, headaches, and water retention. Learn what research shows and when to see a doctor.

↗
12
KNOWLEDGE ARTICLE

CJC-1295 with DAC Dosage Bodybuilding Guide

Typical CJC-1295 with DAC dosage bodybuilding protocols range from 1 to 2 mg weekly. Learn how this long-acting GHRH analog is dosed, stacked, and compared.

↗
13
KNOWLEDGE ARTICLE

Can CJC-1295 Make You Taller? What Science Says

Can CJC-1295 make you taller? Here's what research says about growth hormone, growth plates, and whether this peptide can add height in teens or adults.

↗
16
KNOWLEDGE ARTICLE

Should I Get CJC-1295 With or Without DAC?

Wondering should I get CJC-1295 with or without DAC? Compare the half-life, dosing frequency, GH release pattern, and safety before you decide.

↗
17
KNOWLEDGE ARTICLE

CJC-1295 With DAC Dosage: Bodybuilding Guide

CJC-1295 with DAC dosage in bodybuilding typically ranges from 1 to 2 mg per week, but no protocol is FDA-approved. Here's what research shows.

↗
20
KNOWLEDGE ARTICLE

CJC 1295 Ipamorelin and Alcohol: What to Know

CJC 1295 ipamorelin and alcohol: how drinking affects growth hormone release, recovery, and side effects — plus what researchers say about timing and dosage.

↗